Filip Janku is a Primary Care physician. OpenAlex indexes 669 publications with 27,190 citations (h-index 81); ClinicalTrials.gov lists 18 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Internal Medicine profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H)
Sponsor: National Cancer Institute (NCI)
- Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)
Sponsor: National Cancer Institute (NCI)
- Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- DecipheraProgram year2023504 paymentsResearch$401,227openpaymentsdata.cms.gov ↗
- Eli LillyProgram year20221 paymentResearch$169,979openpaymentsdata.cms.gov ↗
- NovartisProgram year20221 paymentResearch$33,797openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
NIH funding
2 NIH research awards on record, funded 2019–2021 per NIH RePORTER. The latest:
- 12 Clinical and Translational Research Center
University of Tx Md Anderson Can Ctr
FY2021$336,390P30CA016672 - Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)
University of Tx Md Anderson Can Ctr
FY2020$650,759R01CA235620 - 12 Clinical and Translational Research Center
University of Tx Md Anderson Can Ctr
FY2020$335,815P30CA016672
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fei Wang, MD
Cornell University
Michael Hassman, DO
Barbara Rizzardi, MD
Kimball Johnson, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”